Compare Nuvalent Inc (NUVL) vs NEOS S&P 500 High Income ETF (SPYI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvalent Inc vs NEOS S&P 500 High Income ETF — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while NEOS S&P 500 High Income ETF trades at $53.42. The key difference: Nuvalent Inc is trading nearer its 52-week high, NEOS S&P 500 High Income ETF nearer its low. Which is the better fit depends on your goals.
| NUVL | SPYI | |
|---|---|---|
Market Cap | $9.81B | — |
Sector | Technology | Income / Options Overlay |
52-Week High | $123.96 | $54.07 |
52-Week Low | $72.16 | $47.98 |
Enterprise Value | $8.52B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuvalent Inc
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →About NEOS S&P 500 High Income ETF
SPYI is an actively managed ETF designed to generate high monthly income through a data-driven call option strategy on the S&P 500 Index. Unlike traditional covered call funds that often forfeit significant upside, SPYI utilizes a 'call spread' approach—selling near-the-money calls while buying out-of-the-money calls—to capture a portion of equity appreciation in rising markets. It prioritizes tax efficiency by utilizing Section 1256 contracts and tax-loss harvesting to provide investors with high-yield monthly distributions.
Read more on SPYI →
